The higher the expression of BSG in bladder carcinoma, cervical squamous cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, rectal adenocarcinoma, sarcoma, and skin cutaneous melanoma, the worse the patient survival (Figure 7B). This evidence concerns the gene BSG and lung adenocarcinoma.